FIELD: autoimmune diseases. SUBSTANCE: depending on nature and gravity of condition, sodium salt of DNA in single dose 0.5-4.0 mg/kg is parenterally administered once every fourth day in combination with administration (subcutaneously, intramuscularly, or intravenously) of human alpha-fetoprotein in single dose 500 to 5000 un/kg 1-2 times daily. Duration of treatment varies from 14 to 30 days. The two preparations can be applied together in one syringe. EFFECT: enhanced treatment efficiency and prolonged average remission term. 2 cl, 7 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR TREATING MALIGNANT TUMORS | 1995 | 
 | RU2105567C1 | 
| MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 | 
 | RU2440133C2 | 
| METHOD OF CHRONIC VIRUS HEPATITIS TREATMENT | 2008 | 
 | RU2369403C1 | 
| CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 | 
 | RU2447897C2 | 
| METHOD OF TREATING HYPOTHYROIDISM | 2009 | 
 | RU2407533C1 | 
| METHOD FOR TREATMENT OF HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS | 2015 | 
 | RU2580301C1 | 
| METHOD OF TREATING MODERATELY ACTIVE AND REPLICATIVE CHRONIC VIRAL HEPATITIS TYPE C OF 1-GENOTYPE | 2009 | 
 | RU2398582C1 | 
| METHOD OF TREATING CHRONIC HEPATITIS IN CHILDREN | 2014 | 
 | RU2553179C1 | 
| METHOD OF CHRONIC OPISTHORCHIASISES TREATMENT IN PATIENTS WITH CHRONIC AUTOIMMUNE THYROIDITIS | 2010 | 
 | RU2414219C1 | 
| METHOD OF TREATMENT OF ACUTE VIRAL HEPATITIS B | 2001 | 
 | RU2207135C2 | 
Authors
Dates
1999-09-20—Published
1995-12-05—Filed